Beam Therapeutics BEAM
NASDAQ BEAM
$24.05 -0.51 (-2.08%)
At close: Oct 23, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Cash & Current Investments (2019 - 2026)

Updated

Beam Therapeutics (BEAM) posted Cash & Current Investments of $1.15 billion for Q2 2026, up 0.2% from $1.15 billion a year earlier but down 4.8% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Beam Therapeutics' Cash & Current Investments came in at $1.25 billion, up 46.4% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 33.0% (FY2020 to FY2025).
  • In prior years, Beam Therapeutics' Cash & Current Investments was $850.74 million in FY2024 (-28.5%), $1.19 billion in FY2023 (+10.4%), $1.08 billion in FY2022 (+92.5%) and $559.99 million in FY2021 (+86.9%).
  • Quarterly Cash & Current Investments has run from a low of $156.51 million in Q3 2022 to a high of $1.25 billion in Q4 2025 over five years.
  • On a year-over-year basis, Cash & Current Investments increased in five of the last eight quarters, with growth averaging 6.3%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2023, with growth of 548.8%; the weakest was Q3 2022, with a decline of 83.2%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $1.21 billion (Q1 2026), $1.25 billion (Q4 2025) and $1.07 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Beam Therapeutics 2.51 Bn -2.18 Bn - 1.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.15 Bn
Mar 31, 2026 1.21 Bn
Dec 31, 2025 1.25 Bn
Sep 30, 2025 1.07 Bn
Jun 30, 2025 1.15 Bn
Mar 31, 2025 1.22 Bn
Dec 31, 2024 850.74 Mn
Sep 30, 2024 925.76 Mn
Jun 30, 2024 1.01 Bn
Mar 31, 2024 1.09 Bn
Dec 31, 2023 1.19 Bn
Sep 30, 2023 1.02 Bn
Jun 30, 2023 1.07 Bn
Mar 31, 2023 1.06 Bn
Dec 31, 2022 1.08 Bn
Sep 30, 2022 156.51 Mn
Jun 30, 2022 265.62 Mn
Mar 31, 2022 296.82 Mn
Dec 31, 2021 559.99 Mn
Sep 30, 2021 933.41 Mn
API Access

Beam Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BEAM&period=max&api_key=YOUR_API_KEY